MARC Record from marc_columbia

LEADER: 04342mam a2200457 a 4500
001 4055248
005 20221027025247.0
008 970327t19971997nyua b 001 0 eng c
010 $a 97011742
020 $a0824794966 (hardcover : alk. paper)
035 $a(OCoLC)ocm36682374
035 $9AML8346HS
035 $a4055248
040 $aDNLM/DLC$cDLC$dNLM$dNNC-M$dOrLoB-B
050 00 $aRC591$b.B47 1997
060 00 $aW1$bLU62 v.106 1997
060 10 $aQV 129$bB563 1997
082 00 $a616.2/38061$221
245 00 $aBeta2-agonists in asthma treatment /$cedited by Romain Pauwels, Paul M. O'Byrne.
260 $aNew York :$bDekker,$c[1997], ©1997.
300 $axvi, 443 pages :$billustrations, portraits ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aLung biology in health and disease ;$v106
500 $aOn t.p. "2" is subscript.
504 $aIncludes bibliographical references and index.
505 00 $tIntroduction /$rClaude Lenfant --$g1.$tOn the History of Sympathomimetics in Asthma /$rCarl G. A. Persson --$g2.$tMolecular Biology of the Beta[subscript 2]-Adrenergic Receptor: Focus on Interactions of Agonist with Receptor /$rStephen B. Liggett and Stuart A. Green --$g3.$tEffect of Beta-Agonists on Airway Effector Cells /$rPeter J. Barnes --$g4.$tEffects of Beta[subscript 2]-Agonists on Airway Inflammation /$rPeter Howarth --$g5.$tPharmacokinetics of Beta[subscript 2]-Adrenoceptor-Stimulating Drugs /$rLars Nyberg --$g6.$tMechanisms of Duration of Action in Inhaled Long-acting Beta[subscript 2]-Adrenoceptor Agonists /$rKlaus F. Rabe and Anders Linden --$g7.$tBronchodilatation /$rEric Derom and Romain Pauwels --$g8.$tEffects of Beta[subscript 2]-Agonists on Airway Responsiveness and Allergen-Induced Responses /$rPaul M. O'Byrne --$g9.$tEffect of Beta-Adrenergic Agonists on Cough and Mucociliary Clearance /$rKian Fan Chung --$g10.$tInhalation Technique and Inhalation Devices /$rMyrna Dolovich --
505 80 $g11.$tAdverse Effects of Beta[subscript 2]-Agonists /$rCarl D. Burgeas, Richard Beasley and Julian Crane [et al.] --$g12.$tClinical Studies of Beta-Agonists in Adults /$rA. E. Tattersfield --$g13.$tClinical Studies of Beta[subscript 2]-Adrenergic Agonists in Children /$rF. Estelle R. Simons --$g14.$tTolerance with Beta[subscript 2]-Agonists: A Clinical Problem? /$rBrian Jonathon Lipworth --$g15.$tRole of Beta[subscript 2]-Agonists in the Treatment of Asthma in Adults /$rRomain Pauwels --$g16.$tThe Role of Beta[subscript 2]-Agonists in the Treatment of Asthma in Children /$rSoren Pedersen.
520 $aThis authoritative, timely resource analyzes every important topic related to the most frequently prescribed anti-asthma medications - comprehensively examining the use of beta[subscript 2]-agonists from molecular interactions with the beta-receptor to clinical and therapeutic applications in acute and chronic conditions.
520 8 $aWritten by world-renowned experts representing prestigious institutions in 12 countries and containing over 1650 bibliographic citations, Beta[subscript 2]-Agonists in Asthma Treatment is an indispensable reference for pulmonologists and pulmonary disease specialists; physiologists; allergists; immunologists; molecular, cellular, and lung biologists; pharmaceutical scientists; pharmacologists; and graduate and medical school students in these disciplines.
650 0 $aAsthma$xChemotherapy.$0http://id.loc.gov/authorities/subjects/sh97008844
650 0 $aAdrenergic beta agonists$xTherapeutic use.
650 12 $aAdrenergic beta-Agonists$xpharmacology.$0https://id.nlm.nih.gov/mesh/D000318Q000494
650 12 $aAdrenergic beta-Agonists$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D000318Q000627
650 22 $aBronchodilator Agents$xpharmacology.$0https://id.nlm.nih.gov/mesh/D001993Q000494
650 22 $aBronchodilator Agents$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D001993Q000627
650 22 $aAsthma$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D001249Q000188
700 1 $aPauwels, Romain.$0http://id.loc.gov/authorities/names/n86063120
700 1 $aO'Byrne, Paul M.,$d1951-$0http://id.loc.gov/authorities/names/n88095350
830 0 $aLung biology in health and disease ;$vv. 106.$0http://id.loc.gov/authorities/names/n83701685
852 00 $boff,hsl$hRC591$i.B47 1997